| Lastest Insider Transactions Of RIGEL PHARMACEUTICALS INC ( RIGL ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2026-09-01 | Option Exercise | 4,600 | 21.72 | 99,929 | 2026-09-03 19:02:11 |
| RIGL | RIGEL PHARMACEUTICALS INC | Ali-Jackson Kamil | Directior | 2026-06-22 | Sell | 2,500 | 35.00 | 87,500 | 2026-06-24 16:04:28 |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2026-06-01 | Option Exercise | 3,381 | 14.83 | 50,139 | 2026-06-03 18:03:50 |
| RIGL | RIGEL PHARMACEUTICALS INC | Ali-Jackson Kamil | Directior | 2026-05-26 | Sell | 2,500 | 29.17 | 72,925 | 2026-05-28 16:19:05 |
| RIGL | RIGEL PHARMACEUTICALS INC | MOOS WALTER H | Directior | 2026-02-20 | Sell | 4,000 | 36.36 | 145,440 | 2026-02-24 16:58:28 |
| RIGL | RIGEL PHARMACEUTICALS INC | MOOS WALTER H | Directior | 2026-02-20 | Option Exercise | 4,000 | 24.00 | 96,000 | 2026-02-24 16:58:28 |
| RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 2026-01-26 | Option Exercise | 80,000 | 27.40 | 2,192,000 | 2026-02-04 16:20:33 |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2025-12-22 | Option Exercise | 6,500 | 21.51 | 139,786 | 2025-12-29 20:06:30 |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2025-02-04 | Sell | 3,770 | 21.38 | 80,615 | 2025-02-06 20:27:22 |
| RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | 2025-02-04 | Sell | 3,921 | 21.38 | 83,836 | 2025-02-06 20:27:13 |
| RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | 2025-02-04 | Sell | 3,921 | 21.38 | 83,836 | 2025-02-06 20:27:13 |
| RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 2025-02-04 | Sell | 9,352 | 21.39 | 200,075 | 2025-02-06 20:27:03 |
| RIGL | RIGEL PHARMACEUTICALS INC | Furey Raymond J. | EVP, GC, CCO & Corp Sec | 2025-02-04 | Sell | 2,787 | 21.40 | 59,653 | 2025-02-06 20:26:51 |
| RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 2025-01-24 | Option Exercise | 90,000 | 21.40 | 1,926,000 | 2025-01-28 20:49:28 |
| RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | 2024-02-02 | Sell | 14,519 | 1.14 | 16,496 | 2024-02-06 20:18:59 |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2024-02-02 | Sell | 12,628 | 1.14 | 14,338 | 2024-02-06 20:18:43 |
| RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 2024-02-02 | Sell | 52,894 | 1.14 | 60,082 | 2024-02-06 20:18:16 |
| RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | 2023-01-26 | Sell | 20,340 | 1.75 | 35,595 | 2023-02-07 16:30:24 |
| RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | 2023-02-02 | Sell | 5,388 | 1.66 | 8,945 | 2023-02-06 17:41:27 |
| RIGL | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | 2023-02-02 | Sell | 5,389 | 1.66 | 8,946 | 2023-02-06 17:40:54 |
| RIGL | RIGEL PHARMACEUTICALS INC | Dummer Wolfgang | EVP & CMO | 2023-02-02 | Sell | 5,389 | 1.66 | 8,946 | 2023-02-06 17:40:17 |
